OCGN - Ocugen says EU backs a U.S. trial for gene therapy
2024-04-10 10:20:34 ET
More on Ocugen
- Ocugen: A Speculative Buy In Biotech Growing Clinical Trials To Billion-Dollar Revenues
- Ocugen stock gains after FDA nod to initiate Phase 3 trial of gene therapy candidate
- Ocugen advances Phase 1/2 trial for eye disease candidate
- Seeking Alpha’s Quant Rating on Ocugen
- Historical earnings data for Ocugen